Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition

International Journal of Hematology

Volumn 81, Issue 1, 2005, Pages 18-25

  Kobune, Masayoshi ^a   Kawano, Yutaka ^a   Kato, Junji ^a   Ito, Yoshinori ^a   Chiba, Hiroki ^a   Nakamura, Kiminori ^a   Fujimi, Akihito ^a   Matsunaga, Takuya ^a   Hamada, Hirofumi ^a,b   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Erythroblast; Erythropoiesis; Human stromal cells

Indexed keywords

CD34 ANTIGEN; HEMOGLOBIN;

ARTICLE; BURST FORMING UNIT E; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; STROMA CELL; TELOMERE;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; ERYTHROBLASTS; HEMATOPOIETIC STEM CELLS; HUMANS; STROMAL CELLS; TELOMERE;

EID: 19944431850     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04080     Document Type: Article

References (43)

1. Coste I, Gauchat JF, Wilson A, et al. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood. 2001;97:3984-3988.
2. 1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways. Blood. 2001;97:1975-1981.
3. Yanai N, Sekine C, Yagita H, Obinata M. Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis. Blood. 1994;83:2844-2850.
4. Suenobu S, Takakura N, Inada T, et al. A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis. Biochem Biophys Res Commun. 2002;293:1124-1131.
5. Arroyo AG, Yang JT, Rayburn H, Hynes RO. Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity. 1999;11:555-566.
6. Hamamura K, Matsuda H, Takeuchi Y, Habu S, Yagita H, Okumura K. A critical role of VLA-4 in erythropoiesis in vivo. Blood. 1996;87:2513-2517.
7. Wang Z, Miura N, Bonelli A, et al. Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells. Blood. 2002;99:2740-2747.
8. Gibellini D, Bassini A, Re MC, et al. Stroma-derived factor 1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. Br J Haematol. 2000;111:432-440.
9. Sadahira Y, Yoshino T, Monobe Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J Exp Med. 1995;181:411-415.
10. Hanspal M, Smockova Y, Uong Q. Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood. 1998;92:2940-2950.
11. Roy V, Verfaillie CM. Soluble factor(s) produced by adult bone marrow stroma inhibit in vitro proliferation and differentiation of fetal liver BFU-E by inducing apoptosis. J Clin Invest. 1997;100:912-920.
12. Schuetze S, Stenberg PE, Kabat D. The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol. 1993;13:5670-5678.
13. Wada H, Suda T, Miura Y, Kajii E, Ikemoto S, Yawata Y. Expression of major blood group antigens on human erythroid cells in a two phase liquid culture system. Blood. 1990;75:505-511.
14. Okumura N, Tsuji K, Nakahata T. Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood. 1992;80:642-650.
15. Shintani N, Kohgo Y, Kato J, et al. Expression and extracellular release of transferrin receptors during peripheral erythroid progenitor cell differentiation in liquid culture. Blood. 1994;83:1209-1215.
16. Panzenbock B, Bartunek P, Mapara MY, Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood. 1998;92:3658-3668.
17. Neildez-Nguyen TM, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20:467-472.
18. Kapur R, Majumdar M, Xiao X, McAndrews-Hill M, Schindler K, Williams DA. Signaling through the interaction of membrane-restricted stem cell factor and c-kit receptor tyrosine kinase: genetic evidence for a differential role in erythropoiesis. Blood. 1998;91:879-889.
19. Furusawa T, Yanai N, Hara T, Miyajima A, Obinata M. Integrin-associated protein (IAP, also termed CD47) is involved in stroma-supported erythropoiesis. J Biochem (Tokyo). 1998;123:101-106.
20. Sato Y, Hong HN, Yanai N, Obinata M. Involvement of stromal membrane-associated protein (SMAP-1) in erythropoietic microenvironment. J Biochem (Tokyo). 1998;124:209-216.
21. Hanspal M. Importance of cell-cell interactions in regulation of erythropoiesis. Curr Opin Hematol. 1997;4:142-147.
22. Lee G, Spring FA, Parsons SF, et al. Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactions. Blood. 2003;101:1790-1797.
23. v- family integrins through novel integrin-binding mechanisms. Blood. 2001;98:458-466.
24. Yanai N, Satoh T, Obinata M. Endothelial cells create a hematopoietic inductive microenvironment preferential to erythropoiesis in the mouse spleen. Cell Struct Funct. 1991;16:87-93.
25. Inada T, Iwama A, Sakano S, Ohno M, Sawada K, Suda T. Selective expression of the receptor tyrosine kinase, HTK, on human erythroid progenitor cells. Blood. 1997;89:2757-2765.
26. Kuwahara I, Ikebuchi K, Hamada H, et al. Changes in N-glycosylation of human stromal cells by telomerase expression. Biochem Biophys Res Commun. 2003;301:293-297.
27. Kobune M, Kawano Y, Ito Y, et al. Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol. 2003;31:715-722.
28. Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood. 2003;101:532-540.
29. -/- repopulating cells. Blood. 2004;104:1002-1009.
30. Kobune M, Xu Y, Baum C, Kelley MR, Williams DA. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N′,N′′-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo. Cancer Res. 2001;61:5116-5125.
31. Yoshida M, Tsuji K, Ebihara Y, et al. Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture. Br J Haematol. 1997;98:254-264.
32. Dai MS, Heinrich MC, Broxmeyer HE, Lu L. Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors. Cytokines Cell Mol Ther. 2000;6:1-8.
33. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
34. Zermati Y, Fichelson S, Valensi F, et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol. 2000;28:885-894.
35. Telen MJ. Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin Hematol. 2000;37:130-142.
36. Wojda U, Noel P, Miller JL. Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. Blood. 2002;99:3005-3013.
37. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-α antibody therapy. Blood. 2002;100:474-482.
38. Tsuji T, Waga I, Tezuka K, Kamada M, Yatsunami K, Kodama H. Integrin β2 (CD18)-mediated cell proliferation of HEL cells on a hematopoietic-supportive bone marrow stromal cell line, HESS-5 cells. Blood. 1998;91:1263-1271.
39. Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 1993;81:2916-2924.
40. Okamoto T, Aoyama T, Nakayama T, et al. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun. 2002;295:354-361.
41. Serakinci N, Guldberg P, Burns JS, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene. 2004;23:5095-5098.
42. Keith WN. From stem cells to cancer: balancing immortality and neoplasia. Oncogene. 2004;23:5092-5094.
43. Xiaoxue Y, Zhongqiang C, Zhaoqing G, Gengting D, Qingjun M, Shenwu W. Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene. Biochem Biophys Res Commun. 2004;315:643-651.